[go: up one dir, main page]

DK3283511T3 - Modified collagen, methods of manufacture thereof - Google Patents

Modified collagen, methods of manufacture thereof Download PDF

Info

Publication number
DK3283511T3
DK3283511T3 DK16717992.8T DK16717992T DK3283511T3 DK 3283511 T3 DK3283511 T3 DK 3283511T3 DK 16717992 T DK16717992 T DK 16717992T DK 3283511 T3 DK3283511 T3 DK 3283511T3
Authority
DK
Denmark
Prior art keywords
manufacture
methods
modified collagen
collagen
modified
Prior art date
Application number
DK16717992.8T
Other languages
English (en)
Inventor
Spragg Andrew Mearns
Original Assignee
Jellagen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jellagen Pty Ltd filed Critical Jellagen Pty Ltd
Application granted granted Critical
Publication of DK3283511T3 publication Critical patent/DK3283511T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/614—Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16717992.8T 2015-04-13 2016-04-12 Modified collagen, methods of manufacture thereof DK3283511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1506236.7A GB201506236D0 (en) 2015-04-13 2015-04-13 Modified collagen, methods of manufacture thereof
PCT/GB2016/051025 WO2016166524A1 (en) 2015-04-13 2016-04-12 Modified collagen, methods of manufacture thereof

Publications (1)

Publication Number Publication Date
DK3283511T3 true DK3283511T3 (da) 2020-10-19

Family

ID=53333696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16717992.8T DK3283511T3 (da) 2015-04-13 2016-04-12 Modified collagen, methods of manufacture thereof

Country Status (9)

Country Link
US (2) US11485772B2 (da)
EP (1) EP3283511B1 (da)
JP (1) JP7010700B2 (da)
KR (2) KR102652539B1 (da)
DK (1) DK3283511T3 (da)
ES (1) ES2842244T3 (da)
GB (1) GB201506236D0 (da)
IL (1) IL254865B (da)
WO (1) WO2016166524A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
DK2648795T3 (da) 2010-12-08 2023-03-27 Convatec Technologies Inc System til fjernelse af eksudater fra en sårposition
EP2648794B1 (en) 2010-12-08 2019-08-28 ConvaTec Technologies Inc. Wound exudate system accessory
US10207031B2 (en) 2010-12-08 2019-02-19 Convatec Technologies Inc. Integrated system for assessing wound exudates
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
JP2016507663A (ja) 2012-12-20 2016-03-10 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 化学修飾セルロース系繊維の加工
GB201506236D0 (en) * 2015-04-13 2015-05-27 Jellagen Pty Ltd Modified collagen, methods of manufacture thereof
GB2543544A (en) 2015-10-21 2017-04-26 Brightwake Ltd Wound dressing
WO2017173069A1 (en) 2016-03-30 2017-10-05 Convatec Technologies Inc. Detecting microbial infections in wounds
KR20190008199A (ko) 2016-03-30 2019-01-23 시노보 게엠베하 상처에서 미생물 감염의 검출 방법
GB201608099D0 (en) 2016-05-09 2016-06-22 Convatec Technologies Inc Negative pressure wound dressing
MX2019000232A (es) 2016-07-08 2019-11-12 Convatec Technologies Inc Deteccion de flujo de fluidos.
BR112019000284A2 (pt) 2016-07-08 2019-04-16 Convatec Technologies Inc. aparelho de coleta de fluido
CA3030152A1 (en) 2016-07-08 2018-01-11 Convatec Technologies Inc. Flexible negative pressure system
GB201615205D0 (en) 2016-09-07 2016-10-19 Jellagen Pty Ltd Method
EP3710074B1 (en) 2017-11-16 2024-03-20 ConvaTec Limited Fluid collection apparatus
WO2020245656A1 (en) 2019-06-03 2020-12-10 Convatec Limited Methods and devices to disrupt and contain pathogens
CN110639052B (zh) * 2019-09-30 2021-06-29 新乡医学院 一种促进创面愈合的复合凝胶体系及其制备方法和应用
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
GB202005141D0 (en) 2020-04-07 2020-05-20 Jellagen Pty Ltd Jellyfish collagen use
AU2023268976B2 (en) * 2022-05-12 2025-05-15 Sterile State, Llc Nitric oxide precursors and multi-component compositions for forming the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53121942A (en) * 1977-03-28 1978-10-24 Teruo Miyata Production of hemostatic agent
FR2692582B1 (fr) * 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
US6197745B1 (en) * 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
JP2000230000A (ja) * 1999-02-08 2000-08-22 Hokkaido Univ 一酸化窒素代謝物−ポリオキシアルキレン−ヘモグロビン結合体
FR2801313A1 (fr) 1999-05-19 2001-05-25 Coletica Produit collagenique contenant du collagene d'origine marine a faible odeur et de preference a proprietes mecaniques ameliorees, ainsi que son utilisation sous forme de compositions ou de produits cosmetiques ou pharmaceutiques
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
US8518869B2 (en) * 2004-03-29 2013-08-27 Austria Wirtschaftsservice Gesellschaft M.B.H. Pharmaceutical combined preparation containing a therapeutic protein
GB0505035D0 (en) 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
JP5099623B2 (ja) 2007-03-01 2012-12-19 独立行政法人日本原子力研究開発機構 免疫蛋白質の製造方法
CA2599082A1 (en) * 2007-08-27 2009-02-27 Ping I. Lee Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
JP5167729B2 (ja) 2007-08-31 2013-03-21 ニプロ株式会社 Ｓ−ニトロソ基含有アルブミン及びその製造方法ならびに抗がん剤
CN105709259A (zh) * 2008-01-16 2016-06-29 科麦德有限公司 由水母制成的胶体胶原蛋白凝胶
WO2011015884A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
US9238688B2 (en) 2010-06-15 2016-01-19 National University Corporation NARA Institute of Science and Technology Retinol-modified collagen, method for producing same, and external composition for skin containing same
JP5803267B2 (ja) 2011-05-23 2015-11-04 ニプロ株式会社 Ｓ−ニトロソ化α１−酸性糖タンパク質を含有する抗菌剤
US11103622B2 (en) * 2013-02-07 2021-08-31 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (SNAP)-doped nitric oxide release polymers with enhanced stability
GB201506236D0 (en) * 2015-04-13 2015-05-27 Jellagen Pty Ltd Modified collagen, methods of manufacture thereof

Also Published As

Publication number Publication date
EP3283511B1 (en) 2020-10-14
KR20240043819A (ko) 2024-04-03
ES2842244T3 (es) 2021-07-13
KR20170135918A (ko) 2017-12-08
WO2016166524A1 (en) 2016-10-20
KR102652539B1 (ko) 2024-03-29
US20230065054A1 (en) 2023-03-02
US11485772B2 (en) 2022-11-01
EP3283511A1 (en) 2018-02-21
IL254865B (en) 2021-07-29
GB201506236D0 (en) 2015-05-27
JP2018512441A (ja) 2018-05-17
IL254865A0 (en) 2017-12-31
KR102829973B1 (ko) 2025-07-04
US20180118809A1 (en) 2018-05-03
US12264192B2 (en) 2025-04-01
JP7010700B2 (ja) 2022-01-26

Similar Documents

Publication Publication Date Title
DK3283511T3 (da) Modified collagen, methods of manufacture thereof
PL4279535T3 (pl) Sposoby wytwarzania polioli
PL3167096T3 (pl) Dwuetapowy sposób nanoszenia
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
LT3237432T (lt) Baltymo gamyba
DK3209323T3 (da) Forbedret koaguleringssammensætning
DK3341479T3 (da) LNA-G-Proces
PL4140976T3 (pl) Sposób wytwarzania HCFO-1233ZD
DK3283210T3 (da) Fremgangsmåde
EP3373918C0 (en) PRODUCTION OF CARBOXYLATED NANOCELLULOSES
MA41451A (fr) Constructions anti-tau
DK3283041T3 (da) Collagenstimuleringsanordning
PL3393468T3 (pl) Metody leczenia niedoboru odporności
DK3374495T3 (da) Forbedrede fremgangsmåder til vævsfremstilling
DK3143123T3 (da) Mikrorna-induktion af kardiologisk regenerering
IL254502B (en) Solid forms of menaquinols
EP3384016A4 (en) MANIPULATED PHAGEMIDES
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
LT3253772T (lt) Diosmino ruošimo būdas
FR3041605B1 (fr) Coupole de rotor, rotor et giravion
DK3285588T3 (da) Fremgangsmåde
LT3493849T (lt) N,n-bis-2-merkaptoetilizoftalamido naujas panaudojimas
PL3350308T3 (pl) Zastosowanie włókna liocelowego
LT3183264T (lt) Pegilinimo būdas
BR302014002143S1 (pt) Configuração aplicada em cascata artificial